Gynecology

Latest News



Meet 'Evatar'

2017 is an incredibly exciting time for reproductive biotechnology that is going to greatly improve patient care.

Ovary biotechnology

Several advances in ovarian biotechnology may accelerate ovarian stimulation research.

One study looks at whether or not women with histories of breast or ovarian cancer are receiving necessary genetic testing. Plus: Can in-office hysteroscopy reliably evaluate uterine pathology? Also, researchers say mammographic density changes should be monitored in patients undergoing hormone therapy as a possible indicator of breast cancer.

Hysterectomy is the most common nonobstetric surgical procedure performed on women, with 1 out of 9 women undergoing it in their lifetime. Recent reports have indicated a sharp decline in the number of hysterectomies performed annually in the United States.

When the head of a Kansas woman's baby did not descend easily, the nurse-midwife managing the labor sought an obstetrician’s intervention. The obstetrician used forceps to assist the delivery. The parents sued the obstetrician after the delivery alleging the infant suffered a skull fracture, lacerated ear, bruising around his scalp, and bleeding in the brain as a result of the forceps. What's the verdict? Plus more cases.

Physiologic changes during pregnancy affect the body’s hormonal milieu as well as a woman’s sexual desires, responses, and practices. In this review, we discuss knowledge gaps, the physiology of the female sexual response during pregnancy, types of sexual activity during pregnancy, and existing literature on anatomic and physiologic changes by trimester and postpartum.

Early imaging is key to detecting anomalies, some of which are unique to multiple gestations and some that also occur with singletons. Any anomaly that occurs in singletons can occur in 1 fetus in a multifetal pregnancy.

Contemporary OB/GYN congratulates Founding Editor John T. Queenan, MD, on the lifetime achievement award presented to him at the 9th Philadelphia Prenatal Conference. Held June 8 to 10 in the city for which it was named, the event was jointly sponsored by the American College of Obstetricians and Gynecologists and the Philadelphia Prenatal Diagnosis Institute/The Philadelphia pregnancy, Genetics and Ultrasound Center.

A California woman was 35-years-old when she delivered an infant with severe Down's syndrome and then sued all those involved with the prenatal care and alleged that both physicians were told the parents wanted all available testing because of a family history of birth defects. What's the verdict? Plus more cases.

Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Approximately 90% of women being treated at hemophilia centers in the United States carry the diagnosis of VWD. Because women experience the hemostatic bleeding challenges of menstruation and childbirth, they are disproportionately affected by VWD.

A woman sues her ob/gyn claiming that 3 miscarriages occurred because of an IUD that the ob/gyn believed had been expelled shortly after implantation, but was subsequently found using abdominal x-ray. Plus more cases.

A study looks at who is being tested for BRCA mutations as testing becomes more common. Also, a look at the impact of Zika virus on birth defects using benchmark data. Plus: How is the United States doing with infant mortality?

Can adopting quality measures decrease the cesarean rate? Plus: The Government Accountability Office issues a report on power morcellators and the FDA's system of evaluation. Also, does the volume of one type of heart fat indicate the risk of heart disease?